Back to search

Article

Stanniocalcin 2 (STC2) is a potent biomarker of hepatocellular carcinoma with its expression being augmented in Nrf1α-deficient cells, but diminished in Nrf2-deficient cells

2023-05-18

Abstract excerpt

For insights into the fact that liver-specific knockout of Nrf1 leads to development of non-alcoholic steatohepatitis and spontaneous hepatoma, we previously found that loss of Nrf1α (i.e., a full-length isoform encoded by Nfe2l1 ) promotes HepG2-derived tumor growth in xenograft mice, but malgrowth of the xenograft tumor is significantly suppressed by knockout of Nrf2 (encoded by Nfe2l2 ). The mechanism underly...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3b0930e9-0a3a-5bff-a76d-635115f6c815
DOI
10.1101/2023.05.15.540796
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Stanniocalcin 2 (STC2) is a potent biomarker of hepatocellular carcinoma with its expression being augmented in Nrf1α-deficient cells, but diminished in Nrf2-deficient cellsDOI 10.1101/2023.05.15.540796
Select a neighboring publication to make it the new centre.